Thursday, October 30, 2014

5 Best Mid Cap Stocks To Invest In 2014

Large cap natural and organic foods supermarket giant Whole Foods Market, Inc (NASDAQ: WFM), otherwise known as ��hole Wallet��r ��hole Paycheck,��is not the only player in the natural or organics supermarket space for consumers and investors alike as mid cap Sprouts Farmers Market Inc (NASDAQ: SFM) and small caps Fairway Group Holdings Corp (NASDAQ: FWM) and Natural Grocers by Vitamin Cottage Inc (NYSE: NGVC) are also players in the space. It should be mentioned that Whole Foods Market is down 15.7% since the start of the year and has a downward trending technical chart, but�shares are�still up 13% over the past year, up 426.3% over the past five years and up 3,108.6% since January 1992.

Top Industrial Conglomerate Companies To Own In Right Now: Oxford Industries Inc.(OXM)

Oxford Industries, Inc. engages in designing, sourcing, and marketing apparel products primarily in the United States and the United Kingdom. The company?s apparel products comprise a portfolio of company-owned lifestyle brands, as well as company-owned and licensed brands of tailored clothing and golf apparel. Its owned and licensed brands include Tommy Bahama, Lilly Pulitzer, Ben Sherman, Billy London, Oxford Golf, Nickelson, and Arnold Brant. The company also holds licenses to produce and sell various categories of apparel products under the Kenneth Cole, Dockers, and Geoffrey Beene brand names. Its primary product line includes the Tommy Bahama brand men's and women's sportswear and related products for affluent men and women with age of 35 and older; the Lilly Pulitzer brand women's and girl's dresses, sportswear, and other products for young women, young mothers and their daughters, and women; the Ben Sherman brand men's sportswear and related products for men ages 25 to 40; and branded and private label men's suits, sport coats, suit separates, and dress slacks. In addition, the company licenses its Tommy Bahama, Lilly Pulitzer, and Ben Sherman brand names for various products categories, including apparel, accessories, footwear, watches, jewelry, luggage, rugs, wall coverings, fragrances and toiletries, shampoos and soaps, gift products, furniture, ceiling fans, stationery, bedding and home fashions, and table top accessories. Further, it operates restaurants under the Tommy Bahama brand name. It distributes company-owned lifestyle branded products through department stores, specialty stores, company-owned and licensed retail stores, and its e-commerce Websites; and branded and private label tailored clothing products through department stores, specialty stores, national chains, specialty catalogs, mass merchants, and Internet retailers. Oxford Industries, Inc. was founded in 1942 and is based in Atlanta, Georgia.

Advisors' Opinion:
  • [By Roberto Pedone]

    One potential earnings short-squeeze candidate is men's apparel products player Oxford Industries (OXM), which is set to release numbers Tuesday after the market close. Wall Street analysts, on average, expect Oxford Industries to report revenue of $243.48 million on earnings of 98 cents per share.

    If this company can manage to beat or meet Wall Street's earnings estimates this quarter, then it would mark the biggest quarterly gain in the last six quarter.

    The current short interest as a percentage of the float for Oxford Industries is not able at 5.7%. That means that out of the 14.31 million shares in the tradable float, 817,000 shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 3.8%, or by about 29,000 shares. If the bears are caught being too aggressive into a solid quarter, then shares of OXM could soar higher post-earnings as the bears rush to cover some of their bets.

    From a technical perspective, OXM is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock recently sold off hard from its August high of $69.29 to its low of $61.10 with higher-than-average volume flows. Shares of OXM have now started to rebound a bit off that low of $61.10 with strong upside volume flows. That move is quickly pushing shares of OXM within range of triggering a near-term breakout trade.

    If you're bullish on OXM, then I would wait until after its report and look for long-biased trades if this stock manages to break out above its 50-day moving average at $65.77 a share to more resistance at $65.93 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 103,286 shares. If that breakout triggers, then OXM will set up to re-test or possibly take out its 52-week high at $69.28 a share. Any high-volume move above that level will then give OXM a chance t

  • [By Ben Levisohn]

    Not investors in Restoration Hardware (RH). Its shares have dropped 2% in after-hours trading after it reported a profit of 49 cents a share, above forecasts for 43 cents, but offered mixed guidance. Oxford Industries (OXM) is off 7.3% at $60 after it announced a profit of $1.01, ahead of 98 cents consensus forecasts, but lowered its 2013 guidance. Shares of SunEdison (SUNE) have dropped 5.4% to $7.90 after it announced a secondary offering.

  • [By Lauren Pollock]

    Oxford Industries Inc.'s(OXM) fiscal third-quarter earnings fell 70% despite continued sales growth at the apparel company’s Tommy Bahama and Lilly Pulitzer brands.

5 Best Mid Cap Stocks To Invest In 2014: Puma Biotechnology Inc (PBYI)

Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.

PB272 (neratinib (oral))-Breast Cancer

Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.

PB272 (neratinib (intravenous))

The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.

PB357

PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.

The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.

Advisors' Opinion:
  • [By John Udovich]

    Recent news surrounding small cap biotech stocks like�Xencor Inc (NASDAQ: XNCR), Prosensa Holding NV (NASDAQ: RNA),�Puma Biotechnology Inc (NYSE: PBYI),�Geron Corporation (NASDAQ: GERN)
    and TNI BioTech Inc (OTCQB: TNIB) show that while the sector and appetite for biotech�IPOs may have cooled, lottery tickets can still be found or occur in the sector. Just consider the following recent news or trends:

  • [By George Budwell]

    With that being said, developmental biotechs that fall hard on news could be worth taking a look at because they may have fallen for all the wrong reasons. Puma Biotechnology (NYSE: PBYI  ) , for example, plummeted by 25% about a month ago after reporting mid-stage clinical trial data for the company's flagship cancer drug PB272 (neratinib).

5 Best Mid Cap Stocks To Invest In 2014: ENSCO plc(ESV)

Ensco plc, together with its subsidiaries, provides offshore contract drilling services to the oil and gas industry. The company engages in the drilling of offshore oil and natural gas wells by providing its drilling rigs and crews under contracts with international, government-owned, and independent oil and gas companies. As of February 15, 2010, it owned and operated 42 jackup rigs, 4 ultra-deepwater semisubmersible rigs, and 1 barge rig. The company also has 4 ultra-deepwater semisubmersible rigs under construction. It operates in Asia, the Middle East, Australia, New Zealand, Europe, Africa, and North and South America. The company was formerly known as Ensco International plc and changed its name to Ensco plc in March 2010. Ensco plc was founded in 1975 and is based in London, the United Kingdom.

Advisors' Opinion:
  • [By Ben Levisohn]

    Offshore drillers like Transocean (RIG), Seadrill (SDRL) and Noble (NE) have gotten pounded this year. Is it time to buy? Well, if not that, at least its time to become less bearish, say the folks at BMO Capital Markets, who upgraded the shares of Transocean, Seadrill, Diamond Offshore (DO), Ensco (ESV), Noble, Rowan (RDC) and Atwood Oceanics (ATW).

  • [By David Smith]

    Or there's Ensco (NYSE: ESV  ) , owner of the world's second-largest drilling fleet, which earlier this week reported a surprisingly high 20% year-over-year growth in earnings. That's what happens when dayrates climb by 15%. Despite that, the company's forward P/E sits near a paltry 7.4 times. That, despite a forward indicted dividend yield of 3.60%.

  • [By Ben Levisohn]

    Shares of Transocean are unchanged at $40.47 today, while Ensco (ESV) has risen 0.7% to $52.43, Atwood Oceanics (ATW) is little changed at $49.47,�Diamond Offshore�(DO) has risen 0.4% to $47.02 and� Seadrill (SDRL), whose strategy Transocean may be following, has ticked up 0.2% to $34.30.

  • [By Teresa Rivas]

    However a Deutsche downgrade hurt offshore drillers including Transocean (RIG), Diamond Offshore (DO) and Ensco International (ESV). Elsewhere, Michael Kors��(KORS) first quarter didn�� live up to investors��high expectations while McDonald�� (MCD) managed to come back from earlier losses related to the impact of the tainted meat scandal in China.

5 Best Mid Cap Stocks To Invest In 2014: Pazoo Inc (PZOO)

Pazoo, Inc., formerly IUCSS, Inc., incorporated on November 16, 2010, is a development-stage company. The Company is an online retailer and distributer of nutritional foods/supplements, wellness goods, and fitness apparel.

As of December 31, 2011, the Company�� source of revenue was through www.pazoo.com. The Company offers a range of products through various catalogs, such as health and beauty, vitamins and supplements, apparel, accessories, food and beverages, fitness and sports equipments, gifts, videos and books, and pet wellness.

Advisors' Opinion:
  • [By Bryan Murphy]

    For those traders who were lucky and smart enough to be in an Arotech Corporation (NASDAQ:ARTX) before today, then congratulations - you're up at least 38% on your position. Now it's time to get out. Conversely, if you're looking for a new name to get into (or perhaps looking for a place to park your ARTX proceeds), then you may want to consider Pazoo Inc. (OTCBB:PZOO)... a tiny online retailer of health and fitness goods. PZOO has dropped several tell-tale hints that more upside is on the way.

No comments:

Post a Comment